Industry Insights

  1. How To Close The Looming Life Sciences Data Storage Gap 12/9/2022

    Organizations across life sciences are facing a data storage dilemma: how to balance the need to store and potentially monetize mushrooming amounts of data while managing IT budgets and limiting the total cost of ownership.

  2. Meeting Stability Testing Expectations In A Complex Pharma Landscape

    What was once a check-the-box procedure in standard stability testing now requires a deeper understanding of the molecule, its behavior, and what effect it has on the patient.

  3. AI-Powered Digital Pathology For Pulmonary Fibrosis Biomarker Quantification 3/27/2025

    Uncover how AI-driven digital pathology is revolutionizing the detection and quantification of pulmonary fibrosis markers in whole lung sections, offering new opportunities for clinical research.

  4. How Automated Analytical Devices Are Driving Smarter Biomanufacturing 6/27/2025

    Precision is critical in biomanufacturing. Learn how automated analytical devices are providing real-time, high-resolution data for smarter decision-making and enhanced process control.

  5. The Role Of Human Performance Tools & Just Culture In Biopharma Operations 1/20/2017

    The behavior of the people within an organization can be the least predictable part of the business. While the pharmaceutical and biotech industry has been successful in incorporating lean and Six Sigma principles to increase operational and system efficiency, there has been a lack of similar gain demonstrated when dealing with human behavior and human error.

  6. Collaborating To Tighten Timelines And Prepare For IND Filing 8/4/2021

    Emerging biotech company Nkarta sought a CDMO with a high degree of flexibility that could support its analytical development and manufacturing needs and help advance its programs into clinical trials.

  7. Oncology Solutions: Accelerate Your Cancer Therapeutics Development 3/27/2025

    Join the global effort to advance cancer research and contribute to the development of personalized treatments that target the unique characteristics of each patient's disease.

  8. Digging Into Manufacturing Priorities For Viral Vectors 3/18/2025

    Addressing the complexities of viral vector manufacturing through strategic internalization, advanced technologies, and regulatory excellence is crucial for the future of gene therapies.

  9. Optimizing Cell Line Development For Next Generation Biologics 8/21/2024

    CLD platforms must be flexible and efficient to accommodate increasingly complex molecules. Utilizing standardized, modular approaches, as well as strategic partnerships with CDMOs, can help.

  10. 25 Years Of VST Therapies: The Journey Behind The Technology And Innovation 10/19/2021

    This article explains the major stepping stones to preventing and treating serious viral infections in high-risk populations with T cell deficiencies.